Key facts
as of Oct 2026- Developer of a medication management technology designed to support secure handling and oversight of medications outside hospital environments.
- MedServe is valued at approximately $10.5M as of Oct 2026 (last reported valuation).
- It has raised $3.3M; the latest was Later Stage VC ($2.5M) in Feb 2025.
- Notable investors include NVNG Investment Advisors, Locker One Ventures, Nameless Ventures(Chicago), Tomorrow River Ventures.
- Status: Privately Held (backing).
Last reported valuation
LOW confidence$10.5M
MedServe's last reported valuation, Feb 2025. Nothing priced has surfaced since.
Free account
More of MedServe with a free account
- ·Watch MedServe: the Monday email on marks, rounds and moves
Create free account
No card required
Funding rounds
No rounds on record
No funding rounds for MedServe are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
About MedServe
Developer of a medication management technology designed to support secure handling and oversight of medications outside hospital environments. The company offers controlled access, tracking, and compliance features, enabling non-hospital healthcare settings such as ambulatory surgery centres, outpatient clinics, long-term care providers, emergency medical services, veterinary practices, and behavioural health organizations to manage medications safely and consistently.
- Sector
- Healthcare
- HQ
- Milwaukee, WI, United States
- Founded
- 2017
- Employees
- 12
- Website
- medserverx.com/
- Ownership
- Privately Held (backing)